Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CTTI_Trials
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CTTI_Trials
-
Build your own financial model to estimate the value of
#patientengagement on key business drivers such as cost, risk, revenue, and time. Learn how during CTTI’s 2/27 webinar:http://bit.ly/2Rz0Tl9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Identify
#patientengagement activities that bring high value – financial and otherwise – to your#clinicalresearch. Learn more at a CTTI webinar 2/27:http://bit.ly/2Rz0Tl9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CTTI proslijedio/la je Tweet
@CTTI_Trials Transformation Initiative is working to increase the number of trials leveraging telemedicine and mobile nursing to conduct decentralized trials. https://www.ctti-clinicaltrials.org/projects/decentralized-clinical-trials …pic.twitter.com/xNwImlGxCd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#GoodClinicalPractice training is an important step for ensuring safety of#clinicalresearch participants, but many investigators say it is seen as “just another box to check off.” CTTI’s new paper describes opportunities for improving GCP training:http://bit.ly/38A9gm4Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Engaging patients at every stage of clinical research is no longer a “should,” it is a “must”. Jaye Bea Smalley &
@TuftsCSDD’s Joe DiMasi discuss#patientengagement resources during a CTTI webinar 2/27:http://bit.ly/2Rz0Tl9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Could
#GoodClinicalPractice training be improved? New CTTI paper describes stakeholder suggestions for alleviating burden and making training more engaging & applicable to real-world#clinicalresearch scenarios:http://bit.ly/38A9gm4Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
After conducting interviews with diverse stakeholders to learn how institutions are approaching single IRB adoption, CTTI released recs for evaluation & improvement of the process. Watch the January webinar to learn more.
#CommonRulehttp://bit.ly/2RfC4dWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What are your thoughts on
#GoodClinicalPractice training? CTTI compiled feedback from clinical investigators & research sponsors. See challenges they raised & opportunities for improvement in CTTI’s new paper:http://bit.ly/38A9gm4Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you part of an organization involved in implementing single IRB? Watch CTTI’s January webinar to learn more about CTTI’s recs for evaluation and continuous improvement of the
#sIRB process.#CommonRulehttp://bit.ly/2RfC4dWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Webinar now available: CTTI shares recs for evaluation of the single IRB implementation process, as well as existing resources that can help you with
#sIRB implementation today!#CommonRulehttp://bit.ly/2RfC4dWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A strong cross-institutional infrastructure & solid comms approach are critical to achieving long-term sustainability of
#masterprotocols. Read more findings from a recent#CTTI meetinghttp://bit.ly/35YX24LHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Publicly available resources are needed to support orgs that want to conduct
#masterprotocol trials, esp. for non-traditional#drugdevelopers such as#patientadvocacy groups & other nonprofits. Read more themes from a recent#CTTI meetinghttp://bit.ly/35YX24LHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#CTTI meeting attendees identify challenges & potential solutions associated with planning & running#masterprotocol#clinicaltrialshttp://bit.ly/35YX24LHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#CTTI holds 1st meeting to drive appropriate, efficient use of#masterprotocol#clinicaltrialshttp://bit.ly/35YX24LHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TODAY! Don’t miss this
#CTTI webinar on#sIRB resources & suggestions for#sIRB measurement and evaluation.http://bit.ly/2FxUYG5Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TOMORROW! Learn more about
#CTTI’s helpful#sIRB resources & suggestions on how to measure and evaluate sIRB use in collaborative#clinicaltrials during this webinar. http://bit.ly/2FxUYG5 pic.twitter.com/DLQhtyP96y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
THIS WEEK! Want to learn how to adopt single
#IRBs in collaborative#clinicaltrials? Need suggestions for how to measure & improve#sIRBs moving forward? Mark this#CTTI webinar on your calendar today! http://bit.ly/2FxUYG5 pic.twitter.com/1ynk4V6DoY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read all about it! Contemporary
#ClinicalTrials publishes#CTTI recs for a more targeted, risk-based approach to investigator traininghttp://bit.ly/2NegC6CHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Good training programs should give investigators what they need, when they need it. Learn more in this new article on
#CTTI recs for improving investigator qualification in Contemporary#ClinicalTrialshttp://bit.ly/2NegC6CHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Got
#sIRB? Join this#CTTI webinar Thursday to learn more about resources and tools that can help your organization comply with#sIRB requirements in collaborative#clinicaltrials. http://bit.ly/2FxUYG5 pic.twitter.com/Ck5ba2Zdks
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.